Submucous leiomyoma of uterus
ICD-10 D25.0 is a billable code used to indicate a diagnosis of submucous leiomyoma of uterus.
Submucous leiomyomas, also known as submucosal fibroids, are benign tumors that develop within the muscular layer of the uterus, specifically protruding into the uterine cavity. These tumors are composed of smooth muscle and fibrous tissue and can vary in size. They are often asymptomatic but can lead to significant clinical issues such as heavy menstrual bleeding, pelvic pain, and reproductive complications. The presence of submucous leiomyomas can interfere with normal uterine function and may contribute to infertility or pregnancy complications. Diagnosis is typically made through imaging studies such as ultrasound or MRI, and the management may include medical therapy, minimally invasive procedures, or surgical interventions depending on the severity of symptoms and the patient's reproductive plans. Regular follow-up is essential to monitor the growth of the leiomyoma and the patient's symptoms, especially in cases where conservative management is chosen.
Detailed documentation of symptoms, imaging results, and treatment plans.
Management of heavy menstrual bleeding, infertility evaluations, and preoperative assessments.
Ensure that the type and location of the leiomyoma are clearly documented to support the coding.
Clear imaging reports indicating the size, location, and characteristics of the leiomyoma.
Ultrasound or MRI evaluations for suspected fibroids.
Radiologists should provide detailed descriptions to aid in accurate coding.
Used when a patient with a submucous leiomyoma undergoes surgical removal.
Operative report detailing the procedure and findings.
Obstetricians should ensure that the diagnosis aligns with the surgical procedure performed.
Common symptoms include heavy menstrual bleeding, pelvic pain, and pressure symptoms. Some patients may also experience infertility.
Diagnosis is typically made through pelvic ultrasound or MRI, which can visualize the location and size of the leiomyoma.
Treatment options include medical management with hormonal therapies, minimally invasive procedures like hysteroscopic myomectomy, or surgical options such as abdominal myomectomy or hysterectomy.
